Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLEK.L Regulatory News (LEK)

  • There is currently no data for LEK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate update

6 Dec 2021 14:00

RNS Number : 7093U
Lekoil Limited
06 December 2021
 

6 December 2021

 

Lekoil Limited

("LEKOIL" or the "Company")

Corporate update

LEKOIL (AIM: LEK), the oil and gas exploration and production company with a focus on Nigeria and West Africa, notes the announcement by Lekoil Nigeria dated 3 December 2021 with respect to an indicative offer to acquire the ordinary shares in the Company (the "Lekoil Nigeria Announcement"). A copy of the Lekoil Nigeria Announcement can be found on the Company's website at www.lekoilplc.com.

The Company notes that it has had no approach from Lekoil Nigeria and has had no discussions with Lekoil Nigeria with respect to any offer to acquire the ordinary shares in the Company (the "Shares").

The Company will liaise with its Nominated Advisor, legal counsel and shareholders in the coming days to address the issues raised by the Lekoil Nigeria Announcement.

The Company notes that the Lekoil Nigeria Announcement is factually incorrect and/or misleading in several ways, as set out below.

In the interim, the Company encourages its shareholders to vote by way of proxy in the upcoming Annual General Meeting, set for 21 December 2021.

 

The Company notes the following with respect to the Lekoil Nigeria Announcement

1. Indicative offer: Whilst noting that a further "offer" will be made prior to 14 December 2021, the Company notes that the Lekoil Nigeria Announcement does not contain the level of detail on price, structure or proof of finance that would make it an offer capable of acceptance.

The Company notes that the mechanism by which Lekoil Nigeria proposes to purchase the Shares is not clear. The Company believes it is in the interest of shareholder for Lekoil Nigeria to work with the Company to have the Shares unsuspended so that any offer can be made to shareholders in a liquid market.

It is not clear to the Company how the issuance of shares in Lekoil Nigeria, in exchange for Shares in the Company, would benefit shareholders in terms of retaining liquidity in publicly traded shares, but we await further details from Lekoil Nigeria in this regard.

The Company notes that any offer to purchase Shares is not governed by the UK's Takeover Code. The Company's Articles of Association include an equivalent to Rule 9 of the Takeover Code, which would, in effect, require any shareholder who obtains 30% of the Shares to make an offer to purchase all the remaining Shares.

2. Dilution: As stated by the Company in its corporate update dated 27 October 2021, the use of the Contractor Shares Arrangement ("CSA") was authorised by shareholders at the 2020 Annual General Meeting. The use of the CSA and the entry into the Convertible Facility Agreement ("CFA") were in response to the fact that Lekoil Nigeria has, from mid-2021, refused to fund the Company. Historically, the costs of the Company have been paid by Lekoil Nigeria (or its subsidiaries) and set-off against the inter-company debt owing by the relevant subsidiary to the Company.

The Company is seeking authority at the 2021 Annual General Meeting ("2021 AGM") to continue the use of the CSA and will manage the implementation of the CSA in a prudent manner, balancing cash management with shareholder dilution. The Board currently expects that the issuance of Contractor Shares in 2021 will be circa 5% of the current issued share capital. The CFA, if fully repaid in Shares, would be circa 7.5% of the current issued share capital.

The actual use of the CSA in 2022 will depend, in part, on the other finance options available to the Company. The Company would, for example, be able to minimise the use of the CSA and repay the CFA (and therefore minimise dilution), if Lekoil Nigeria used its available cash (circa USD$3m at 1 September 2021) to repay part of the intercompany debt due from Lekoil Nigeria to the Company or repay receivables due and owing to the Company.

A further source of financing that would protect shareholders from dilution and incurring further expenses would be the repayment of Mr. Akinyanmi's loan.

As previously stated, the Company's intent was to conduct an open offer in Q4 2021, to help fund the business. The current suspension of the Company's shares impacts the ability to successfully implement the open offer at this time but the Company will seek to do so as soon as trading in the Shares is unsuspended.

The Company notes that the reference to 40% dilution will not be possible as, per Resolution 7 of the 2021 AGM, the maximum authority to allot Shares for all purposes (including the open offer and the implementation of the CSA), is circa 33%.

3. Re-admission to trading: It is factually incorrect for Lekoil Nigeria to say that the Company needs to "reapply to the London Stock Exchange for a new admission to listing". A "re-application" implies, for example, a new admission document. This is simply not the case. The Company is working with its Nominated Advisor on matters that are required for the Shares to be unsuspended and indeed has shared with Lekoil Nigeria the details of action items required to complete this process and asked for its assistance to complete the tasks. To date, the Company is still waiting on Lekoil Nigeria to complete these tasks.

4. Board of Directors: Lekoil Nigeria state that the cost of the current Board of Directors "is in excess of US$500,000 and up to $1,000,000 per year". This is factually incorrect. It is expected that the ongoing annual cost of the Board will be less than US$300,000, to be paid in Shares with the conversion price in excess of the current share price. This compares to a cash cost of USD$1.36m for 2020.

5. Governance and regulatory issues: The Lekoil Nigeria Announcement makes a number of statements and allegations about the governance of the Company, its Board composition and rationale. The Company sees no merit in responding in detail to these unsupported statements and allegations given the well documented actions of Lekoil Nigeria in seeking to take control of the assets of the Lekoil Cayman group despite the investment made in the Lekoil Cayman group by the Company's shareholders.

 

For further information, please visit www.lekoilplc.com or contact:

SP Angel Corporate Finance LLP (Nominated Adviser and Joint Broker)

Jeff Keating / Stuart Gledhill

 

+44 20 3470 0470

Tennyson Securities (Joint Broker)

Peter Krens / Edward Haig-Thomas

+44 20 7186 9030

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUNUORASUURAA
Date   Source Headline
22nd Dec 202012:24 pmRNSRE Extraordinary General Meeting
18th Dec 20207:15 amRNSRe Otakikpo Marginal Field
18th Dec 20207:00 amRNSExtension of Director Loan
17th Dec 202012:58 pmRNSRE Extraordinary General Meeting
11th Dec 20208:00 amRNSPosting of Circular and Notice of EGM
11th Dec 20207:00 amRNSPayments to Optimum Petroleum Development Company
23rd Nov 20206:03 pmRNSRequisition of Extraordinary General Meeting
23rd Nov 20207:30 amRNSSuspension - Lekoil Limited
23rd Nov 20207:15 amRNSNominated Adviser Update
19th Nov 20202:45 pmRNSHolding(s) in Company
16th Nov 20204:41 pmRNSSecond Price Monitoring Extn
16th Nov 20204:36 pmRNSPrice Monitoring Extension
16th Nov 20202:05 pmRNSSecond Price Monitoring Extn
16th Nov 20202:00 pmRNSPrice Monitoring Extension
16th Nov 202011:05 amRNSSecond Price Monitoring Extn
16th Nov 202011:00 amRNSPrice Monitoring Extension
16th Nov 20207:00 amRNSResignation of Nominated Adviser
11th Nov 20207:00 amRNSRepayment of Prepayment Facility
30th Oct 20207:00 amRNSInterim Results 2020
29th Oct 20207:00 amRNSStrategic Alliance Agreement with NAMCOR
28th Sep 20207:00 amRNSInterims Reporting Timeline and Optimum Payment
25th Sep 20204:46 pmRNSResult of AGM and Board Changes
2nd Sep 20207:00 amRNSAnnual Report and Notice of Annual General Meeting
1st Sep 202011:54 amRNSTR-1: notification of major holdings
26th Aug 20207:05 amRNSHolding(s) in Company
26th Aug 20207:00 amRNSFinal Results
25th Aug 20207:00 amRNSJoint Broker Appointment
17th Aug 20207:00 amRNSRestructuring of Existing Term Loans
23rd Jul 202012:08 pmRNSSecond Price Monitoring Extn
23rd Jul 202012:02 pmRNSPrice Monitoring Extension
15th Jul 20205:10 pmRNSConfirmation of completed Optimum Payment
15th Jul 20204:00 pmRNSJoint Broker Resignation
13th Jul 20207:00 amRNSAgreements for Otakikpo Drilling Executed
10th Jul 20207:00 amRNSHolding(s) in Company
3rd Jul 20204:41 pmRNSSecond Price Monitoring Extn
3rd Jul 20204:36 pmRNSPrice Monitoring Extension
2nd Jul 20207:00 amRNSPrepayment Facility
26th Jun 20207:00 amRNSExtension of annual results and trading update
17th Jun 202012:08 pmRNSSecond Price Monitoring Extn
17th Jun 202012:02 pmRNSPrice Monitoring Extension
15th Jun 20204:41 pmRNSSecond Price Monitoring Extn
15th Jun 20204:36 pmRNSPrice Monitoring Extension
8th Jun 20207:00 amRNSTR-1: notification of major holdings
29th May 20204:41 pmRNSSecond Price Monitoring Extn
29th May 20204:36 pmRNSPrice Monitoring Extension
30th Apr 20207:00 amRNSRe-structure of Financial Obligations to Optimum
24th Apr 202012:08 pmRNSSecond Price Monitoring Extn
24th Apr 202012:02 pmRNSPrice Monitoring Extension
21st Apr 20207:00 amRNSDirectorate Changes
20th Apr 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.